Breaking News
Get 40% Off 0
Join +750K new investors every month who copy stock picks from billionaire's portfolios Sign Up Free
Close

Abivax SA (ABVX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.84 -1.04    -8.07%
11:35:25 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 30,581
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 11.78 - 12.72
Type:  Equity
Market:  France
ISIN:  FR0012333284 
Abivax SA 11.84 -1.04 -8.07%

Abivax SA Company Profile

 
Get an in-depth profile of Abivax SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

61

Equity Type

ORD

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

Contact Information

Address 7-11 boulevard Haussmann
Paris, 75009
France
Phone 33 1 53 83 09 63
Fax -

Top Executives

Name Age Since Title
Claude Bertrand 61 2014 Member of Scientific Advisory Board
Christian Trepo - - Member of Scientific Advisory Board
Christoph Hubert Huber 79 - Member of Scientific Advisory Board
Luc Teyton - - Member of Scientific Advisory Board
Lawrence R. Stanberry - - Member of Scientific Advisory Board
Ian McGowan - 2018 Chairman of Scientific Advisory Board
June H. Lee 57 2023 Independent Director
Troy A. Ignelzi 55 2023 Independent Director
Christian Brechot 70 2017 Member of Scientific Advisory Board
Corinna Zur Bonsen-Thomas - 2017 Independent Non-Executive Director
Carol L. Brosgart 71 2018 Independent Non-Executive Director
Kinam Hong - 2019 Non-Executive Director
Jurgen Rockstroh - 2018 Member of Scientific Advisory Board
Camilla Soenderby 52 2024 Independent Director
Philippe Pouletty 66 2013 Founder & Director
Marc M. P. de Garidel 66 2023 CEO & Interim Chair of Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABVX Comments

Write your thoughts about Abivax SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email